<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1">

<meta name="author" content="Andrew Bean, Sebastian Weber" />

<meta name="date" content="2019-11-18" />

<title>Guiding Oncology Dose-Escalation Trials</title>



<style type="text/css">code{white-space: pre;}</style>
<style type="text/css" data-origin="pandoc">
a.sourceLine { display: inline-block; line-height: 1.25; }
a.sourceLine { pointer-events: none; color: inherit; text-decoration: inherit; }
a.sourceLine:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode { white-space: pre; position: relative; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
code.sourceCode { white-space: pre-wrap; }
a.sourceLine { text-indent: -1em; padding-left: 1em; }
}
pre.numberSource a.sourceLine
  { position: relative; left: -4em; }
pre.numberSource a.sourceLine::before
  { content: attr(title);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; pointer-events: all; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {  }
@media screen {
a.sourceLine::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */

</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    for (var j = 0; j < rules.length; j++) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") continue;
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') continue;
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#header {
text-align: center;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; }  code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Guiding Oncology Dose-Escalation Trials</h1>
<h4 class="author">Andrew Bean, Sebastian Weber</h4>
<h4 class="date">2019-11-18</h4>



<!--
%\VignetteEngine{knitr::rmarkdown}
%\VignetteIndexEntry{Guiding Oncology Dose-Escalation Trials}
-->
<div id="introduction" class="section level2">
<h2>Introduction</h2>
<p>The <code>OncoBayes2</code> package provides flexible functions for Bayesian meta-analytic modeling of the incidence of Dose Limiting Toxicities (DLTs) by dose level, under treatment regimes involving any number of combination partners. Such models may be used to support dose-escalation decisions and estimation of the Maximum Tolerated Dose (MTD) in adaptive Bayesian dose-escalation designs.</p>
<p>The package supports incorporation of historical data through a Meta-Analytic-Combined (MAC) framework [1], which stratifies these heterogeneous sources of information through a hierarchical model. Additionally, it allows the use of EXchangeable/Non-EXchangeable (EX/NEX) priors to manage the amount of information-sharing across subgroups of historical and/or concurrent sources of data.</p>
</div>
<div id="example-use-case" class="section level2">
<h2>Example use-case</h2>
<p>Consider the application described in Section 3.2 of [1], in which the risk of DLT is to be studied as a function of dose for two drugs, drug A and drug B. Historical information on the toxicity profiles of these two drugs is available from single agent trials <code>trial_A</code> and <code>trial_B</code>. The historical data for this example is available in an internal data set.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb1-1" title="1"><span class="kw">kable</span>(hist_combo2)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">cohort_time</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">8.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">33.3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">50.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">100.0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">200.0</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">400.0</td>
<td align="right">15</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">800.0</td>
<td align="right">20</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">1120.0</td>
<td align="right">17</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The objective is to aid dosing and dose-escalation decisions in a future trial, <code>trial_AB</code>, in which the drugs will be combined. Additionally, another investigator-initiated trial <code>IIT</code> will study the same combination concurrently. Note that these as-yet-unobserved sources of data are included in the input data as unobserved factor levels. This mechanism allows us to specify a joint meta-analytic prior for all four sources of historical and concurrent data.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb2-1" title="1"><span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)</a></code></pre></div>
<pre><code>## [1] &quot;trial_A&quot;  &quot;trial_B&quot;  &quot;IIT&quot;      &quot;trial_AB&quot;</code></pre>
<div id="fitting-the-model" class="section level3">
<h3>Fitting the model</h3>
<p>To fit the hierarchical model described in [4], one makes a call to the function <code>blrm_exnex</code>, as below; although we slightly deviate from the model in [4] by allowing an EXchangeable/Non-EXchangeable prior for the drug components.</p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb4-1" title="1"><span class="co">## Load involved packages</span></a>
<a class="sourceLine" id="cb4-2" title="2"><span class="kw">library</span>(RBesT)  <span class="co">## defines logit function</span></a>
<a class="sourceLine" id="cb4-3" title="3"><span class="kw">library</span>(dplyr)  <span class="co">## for mutate</span></a>
<a class="sourceLine" id="cb4-4" title="4"><span class="kw">library</span>(tidyr)  <span class="co">## defines expand_grid</span></a>
<a class="sourceLine" id="cb4-5" title="5"></a>
<a class="sourceLine" id="cb4-6" title="6"><span class="co">## Design parameters ---------------------</span></a>
<a class="sourceLine" id="cb4-7" title="7"></a>
<a class="sourceLine" id="cb4-8" title="8">dref &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="dv">3</span>, <span class="dv">960</span>)</a>
<a class="sourceLine" id="cb4-9" title="9">num_comp &lt;-<span class="st"> </span><span class="dv">2</span> <span class="co"># two investigational drugs</span></a>
<a class="sourceLine" id="cb4-10" title="10">num_inter &lt;-<span class="st"> </span><span class="dv">1</span> <span class="co"># one drug-drug interaction needs to be modeled</span></a>
<a class="sourceLine" id="cb4-11" title="11">num_groups &lt;-<span class="st"> </span><span class="kw">nlevels</span>(hist_combo2<span class="op">$</span>group_id) <span class="co"># four groups of data</span></a>
<a class="sourceLine" id="cb4-12" title="12">num_strata &lt;-<span class="st"> </span><span class="dv">1</span> <span class="co"># no stratification needed</span></a>
<a class="sourceLine" id="cb4-13" title="13"></a>
<a class="sourceLine" id="cb4-14" title="14"><span class="co">## abbreviate labels (wait for prior_summary)</span></a>
<a class="sourceLine" id="cb4-15" title="15"><span class="kw">options</span>(<span class="dt">OncoBayes2.abbreviate.min=</span><span class="dv">8</span>)</a>
<a class="sourceLine" id="cb4-16" title="16"></a>
<a class="sourceLine" id="cb4-17" title="17"><span class="co">## disables abbreviations (default)</span></a>
<a class="sourceLine" id="cb4-18" title="18"><span class="co">#options(OncoBayes2.abbreviate.min=0)</span></a>
<a class="sourceLine" id="cb4-19" title="19"></a>
<a class="sourceLine" id="cb4-20" title="20"><span class="co">## STRONGLY RECOMMENDED =&gt; uses 4 cores</span></a>
<a class="sourceLine" id="cb4-21" title="21"><span class="kw">options</span>(<span class="dt">mc.cores=</span><span class="dv">4</span>)</a>
<a class="sourceLine" id="cb4-22" title="22"></a>
<a class="sourceLine" id="cb4-23" title="23"><span class="co">## Model fit -----------------------------</span></a>
<a class="sourceLine" id="cb4-24" title="24"></a>
<a class="sourceLine" id="cb4-25" title="25">blrmfit &lt;-<span class="st"> </span><span class="kw">blrm_exnex</span>(</a>
<a class="sourceLine" id="cb4-26" title="26">  <span class="kw">cbind</span>(num_toxicities, num_patients <span class="op">-</span><span class="st"> </span>num_toxicities) <span class="op">~</span></a>
<a class="sourceLine" id="cb4-27" title="27"><span class="st">    </span><span class="dv">1</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(<span class="kw">log</span>(drug_A <span class="op">/</span><span class="st"> </span>dref[<span class="dv">1</span>])) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-28" title="28"><span class="st">    </span><span class="dv">1</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(<span class="kw">log</span>(drug_B <span class="op">/</span><span class="st"> </span>dref[<span class="dv">2</span>])) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-29" title="29"><span class="st">    </span><span class="dv">0</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(drug_A<span class="op">/</span>dref[<span class="dv">1</span>] <span class="op">*</span><span class="st"> </span>drug_B<span class="op">/</span>dref[<span class="dv">2</span>]) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-30" title="30"><span class="st">    </span>group_id,</a>
<a class="sourceLine" id="cb4-31" title="31">  <span class="dt">data =</span> hist_combo2,</a>
<a class="sourceLine" id="cb4-32" title="32">  <span class="dt">prior_EX_mu_mean_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-33" title="33">    <span class="kw">c</span>(<span class="kw">logit</span>(<span class="fl">0.1</span>), <span class="dv">0</span>, <span class="co"># hyper-mean of (intercept, log-slope) for drug A</span></a>
<a class="sourceLine" id="cb4-34" title="34">      <span class="kw">logit</span>(<span class="fl">0.1</span>), <span class="dv">0</span>), <span class="co"># hyper-mean of (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-35" title="35">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-36" title="36">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-37" title="37">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-38" title="38">  ),</a>
<a class="sourceLine" id="cb4-39" title="39">  <span class="dt">prior_EX_mu_sd_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-40" title="40">    <span class="kw">c</span>(<span class="fl">3.33</span>, <span class="dv">1</span>, <span class="co"># hyper-sd of mean mu for (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-41" title="41">      <span class="fl">3.33</span>, <span class="dv">1</span>), <span class="co"># hyper-sd of mean mu for (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-42" title="42">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-43" title="43">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-44" title="44">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-45" title="45">  ),</a>
<a class="sourceLine" id="cb4-46" title="46">  <span class="dt">prior_EX_tau_mean_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-47" title="47">    <span class="kw">c</span>(<span class="kw">log</span>(<span class="fl">0.25</span>), <span class="kw">log</span>(<span class="fl">0.125</span>),</a>
<a class="sourceLine" id="cb4-48" title="48">      <span class="kw">log</span>(<span class="fl">0.25</span>), <span class="kw">log</span>(<span class="fl">0.125</span>)),</a>
<a class="sourceLine" id="cb4-49" title="49">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-50" title="50">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-51" title="51">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-52" title="52">  ),</a>
<a class="sourceLine" id="cb4-53" title="53">  <span class="dt">prior_EX_tau_sd_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-54" title="54">    <span class="kw">c</span>(<span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>,</a>
<a class="sourceLine" id="cb4-55" title="55">      <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>),</a>
<a class="sourceLine" id="cb4-56" title="56">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-57" title="57">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-58" title="58">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-59" title="59">  ),</a>
<a class="sourceLine" id="cb4-60" title="60">  <span class="dt">prior_EX_mu_mean_inter =</span> <span class="dv">0</span>,</a>
<a class="sourceLine" id="cb4-61" title="61">  <span class="dt">prior_EX_mu_sd_inter =</span> <span class="fl">1.121</span>,</a>
<a class="sourceLine" id="cb4-62" title="62">  <span class="dt">prior_EX_tau_mean_inter =</span> <span class="kw">matrix</span>(<span class="kw">log</span>(<span class="fl">0.125</span>), <span class="dt">nrow =</span> num_inter, <span class="dt">ncol =</span> num_strata),</a>
<a class="sourceLine" id="cb4-63" title="63">  <span class="dt">prior_EX_tau_sd_inter =</span> <span class="kw">matrix</span>(<span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="dt">nrow =</span> num_inter, <span class="dt">ncol =</span> num_strata),</a>
<a class="sourceLine" id="cb4-64" title="64">  <span class="dt">prior_is_EXNEX_comp =</span> <span class="kw">rep</span>(<span class="ot">TRUE</span>, num_comp),</a>
<a class="sourceLine" id="cb4-65" title="65">  <span class="dt">prior_is_EXNEX_inter =</span> <span class="kw">rep</span>(<span class="ot">FALSE</span>, num_inter),</a>
<a class="sourceLine" id="cb4-66" title="66">  <span class="co">## historical data is 100% EX</span></a>
<a class="sourceLine" id="cb4-67" title="67">  <span class="co">## new data only 80% EX</span></a>
<a class="sourceLine" id="cb4-68" title="68">  <span class="dt">prior_EX_prob_comp =</span> <span class="kw">matrix</span>(<span class="kw">c</span>(<span class="fl">1.0</span>, <span class="fl">1.0</span>,</a>
<a class="sourceLine" id="cb4-69" title="69">                                <span class="fl">1.0</span>, <span class="fl">1.0</span>,</a>
<a class="sourceLine" id="cb4-70" title="70">                                <span class="fl">0.8</span>, <span class="fl">0.8</span>,</a>
<a class="sourceLine" id="cb4-71" title="71">                                <span class="fl">0.8</span>, <span class="fl">0.8</span>),</a>
<a class="sourceLine" id="cb4-72" title="72">                              <span class="dt">nrow =</span> num_groups,</a>
<a class="sourceLine" id="cb4-73" title="73">                              <span class="dt">ncol =</span> num_comp,</a>
<a class="sourceLine" id="cb4-74" title="74">                              <span class="dt">byrow=</span><span class="ot">TRUE</span>),</a>
<a class="sourceLine" id="cb4-75" title="75">  <span class="dt">prior_EX_prob_inter =</span> <span class="kw">matrix</span>(<span class="dv">1</span>, <span class="dt">nrow =</span> num_groups, <span class="dt">ncol =</span> num_inter),</a>
<a class="sourceLine" id="cb4-76" title="76">  <span class="dt">prior_tau_dist =</span> <span class="dv">1</span></a>
<a class="sourceLine" id="cb4-77" title="77">)</a></code></pre></div>
<p>The function <code>blrm_exnex</code> returns an object from which numerical and graphical posterior summaries can be extracted using OncoBayes2 functions. We recommend making use of the methods described below.</p>
</div>
<div id="summary-of-prior-specification" class="section level3">
<h3>Summary of prior specification</h3>
<p>The function <code>prior_summary</code> provides a facility for printing, in a readable format, a summary of the prior specification.</p>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb5-1" title="1"><span class="kw">prior_summary</span>(blrmfit) <span class="co"># not run here</span></a></code></pre></div>
</div>
<div id="summary-of-posterior" class="section level3">
<h3>Summary of posterior</h3>
<p>The main target of inference is generally the probability of DLT at a selection of possible doses. In order to obtain this inference, one needs to specify the covariate levels of interest (which need not be present in the observed data).</p>
<p>In this case, we are interested in predicitons for <code>trial_AB</code>, with the possible combination doses of drugs A and B below.</p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb6-1" title="1">newdata &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb6-2" title="2">  <span class="dt">group_id =</span> <span class="kw">c</span>(<span class="st">&quot;trial_AB&quot;</span>),</a>
<a class="sourceLine" id="cb6-3" title="3">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">3</span>, <span class="fl">4.5</span>, <span class="dv">6</span>),</a>
<a class="sourceLine" id="cb6-4" title="4">  <span class="dt">drug_B =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">400</span>, <span class="dv">600</span>, <span class="dv">800</span>)</a>
<a class="sourceLine" id="cb6-5" title="5">)</a>
<a class="sourceLine" id="cb6-6" title="6">newdata<span class="op">$</span>group_id &lt;-<span class="st"> </span><span class="kw">factor</span>(newdata<span class="op">$</span>group_id, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id))</a></code></pre></div>
<p>Note it is important that the factor levels associated with <code>newdata$group_id</code> be consistent with the levels of the grouping factor used when calling <code>blrm_exnex</code>. In case you use <code>expand.grid</code>, then the <code>stringsAsFactors = FALSE</code> argument must be used to ensures that the variable will initially be treated as a character. We recommend using the <code>tidyr</code> command <code>expand_grid</code> which avoids casting strings to factors in an uncontrolled manner. The next line converts the <code>group_id</code> column to a factor with the correct set of four levels. Alternativley, we can create the <code>group_id</code> column directly as a <code>factor</code> column within <code>newdata</code>. The code below results in the same <code>newdata</code> in a more compact form.</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb7-1" title="1">newdata &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb7-2" title="2">  <span class="dt">group_id =</span> <span class="kw">factor</span>(<span class="kw">c</span>(<span class="st">&quot;trial_AB&quot;</span>), <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb7-3" title="3">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">3</span>, <span class="fl">4.5</span>, <span class="dv">6</span>),</a>
<a class="sourceLine" id="cb7-4" title="4">  <span class="dt">drug_B =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">400</span>, <span class="dv">600</span>, <span class="dv">800</span>)</a>
<a class="sourceLine" id="cb7-5" title="5">)</a></code></pre></div>
<p>Posterior summary statistics for the DLT rates at these provisional doses can be extracted from the <code>blrmfit</code> object using the <code>summary</code> method.</p>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb8-1" title="1">summ_stats &lt;-<span class="st"> </span><span class="kw">summary</span>(blrmfit, </a>
<a class="sourceLine" id="cb8-2" title="2">                      <span class="dt">newdata =</span> newdata,</a>
<a class="sourceLine" id="cb8-3" title="3">                      <span class="dt">prob =</span> <span class="fl">0.95</span>,</a>
<a class="sourceLine" id="cb8-4" title="4">                      <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="dv">1</span>))</a>
<a class="sourceLine" id="cb8-5" title="5"></a>
<a class="sourceLine" id="cb8-6" title="6"><span class="kw">kable</span>(<span class="kw">cbind</span>(newdata, summ_stats), <span class="dt">digits =</span> <span class="dv">3</span>)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">0</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">1.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">400</td>
<td align="right">0.064</td>
<td align="right">0.149</td>
<td align="right">0.000</td>
<td align="right">0.022</td>
<td align="right">0.627</td>
<td align="right">0.926</td>
<td align="right">0.029</td>
<td align="right">0.046</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">600</td>
<td align="right">0.095</td>
<td align="right">0.162</td>
<td align="right">0.001</td>
<td align="right">0.050</td>
<td align="right">0.724</td>
<td align="right">0.890</td>
<td align="right">0.053</td>
<td align="right">0.057</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">800</td>
<td align="right">0.136</td>
<td align="right">0.172</td>
<td align="right">0.002</td>
<td align="right">0.088</td>
<td align="right">0.796</td>
<td align="right">0.786</td>
<td align="right">0.139</td>
<td align="right">0.074</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">0</td>
<td align="right">0.102</td>
<td align="right">0.187</td>
<td align="right">0.000</td>
<td align="right">0.036</td>
<td align="right">0.823</td>
<td align="right">0.851</td>
<td align="right">0.073</td>
<td align="right">0.076</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.165</td>
<td align="right">0.228</td>
<td align="right">0.004</td>
<td align="right">0.076</td>
<td align="right">0.945</td>
<td align="right">0.722</td>
<td align="right">0.140</td>
<td align="right">0.138</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">600</td>
<td align="right">0.200</td>
<td align="right">0.239</td>
<td align="right">0.007</td>
<td align="right">0.107</td>
<td align="right">0.953</td>
<td align="right">0.632</td>
<td align="right">0.187</td>
<td align="right">0.180</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="right">0.247</td>
<td align="right">0.253</td>
<td align="right">0.010</td>
<td align="right">0.151</td>
<td align="right">0.968</td>
<td align="right">0.523</td>
<td align="right">0.225</td>
<td align="right">0.252</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">0</td>
<td align="right">0.150</td>
<td align="right">0.209</td>
<td align="right">0.002</td>
<td align="right">0.077</td>
<td align="right">0.917</td>
<td align="right">0.743</td>
<td align="right">0.148</td>
<td align="right">0.109</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.217</td>
<td align="right">0.248</td>
<td align="right">0.007</td>
<td align="right">0.119</td>
<td align="right">0.970</td>
<td align="right">0.596</td>
<td align="right">0.202</td>
<td align="right">0.202</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="right">0.257</td>
<td align="right">0.266</td>
<td align="right">0.008</td>
<td align="right">0.154</td>
<td align="right">0.975</td>
<td align="right">0.509</td>
<td align="right">0.220</td>
<td align="right">0.270</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">800</td>
<td align="right">0.308</td>
<td align="right">0.290</td>
<td align="right">0.008</td>
<td align="right">0.205</td>
<td align="right">0.986</td>
<td align="right">0.437</td>
<td align="right">0.200</td>
<td align="right">0.363</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">0</td>
<td align="right">0.214</td>
<td align="right">0.232</td>
<td align="right">0.004</td>
<td align="right">0.134</td>
<td align="right">0.955</td>
<td align="right">0.573</td>
<td align="right">0.238</td>
<td align="right">0.189</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">400</td>
<td align="right">0.284</td>
<td align="right">0.272</td>
<td align="right">0.009</td>
<td align="right">0.183</td>
<td align="right">0.983</td>
<td align="right">0.454</td>
<td align="right">0.232</td>
<td align="right">0.314</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">600</td>
<td align="right">0.327</td>
<td align="right">0.298</td>
<td align="right">0.008</td>
<td align="right">0.229</td>
<td align="right">0.989</td>
<td align="right">0.416</td>
<td align="right">0.193</td>
<td align="right">0.391</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">800</td>
<td align="right">0.375</td>
<td align="right">0.326</td>
<td align="right">0.005</td>
<td align="right">0.274</td>
<td align="right">0.994</td>
<td align="right">0.379</td>
<td align="right">0.166</td>
<td align="right">0.456</td>
</tr>
</tbody>
</table>
<p>Such summaries may be used to assess which combination doses have acceptable risk of toxicity. For example, according the escalation with overdose control (EWOC) design criteria [3], any doses for which the last column does not exceed 25% are eligible for enrollment.</p>
</div>
<div id="data-scenarios" class="section level3">
<h3>Data scenarios</h3>
<p>Before <code>trial_AB</code> is initiated, it may be of interest to test how this model responds in various scenarios for the initial combination cohort(s).</p>
<p>This can be done easily in OncoBayes2 by updating the initial model fit with additional rows of hypothetical data. In the code below, we explore 3 possible outcomes for an initial cohort enrolled at 3 mg Drug A + 400 mg Drug B, and review the modelâ€™s inference at adjacent doses. Note that the <code>update</code> method for accepts an <code>add_data</code> argument which appends the additional data to the existing data of the previous analysis.</p>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb9-1" title="1"><span class="co"># set up two scenarios at the starting dose level</span></a>
<a class="sourceLine" id="cb9-2" title="2"><span class="co"># store them as data frames in a named list</span></a>
<a class="sourceLine" id="cb9-3" title="3">scenarios &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb9-4" title="4">  <span class="dt">group_id  =</span> <span class="kw">factor</span>(<span class="st">&quot;trial_AB&quot;</span>, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb9-5" title="5">  <span class="dt">drug_A =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb9-6" title="6">  <span class="dt">drug_B =</span> <span class="dv">400</span>,</a>
<a class="sourceLine" id="cb9-7" title="7">  <span class="dt">num_patients      =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb9-8" title="8">  <span class="dt">num_toxicities      =</span> <span class="dv">1</span><span class="op">:</span><span class="dv">2</span></a>
<a class="sourceLine" id="cb9-9" title="9">) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">split</span>(<span class="dv">1</span><span class="op">:</span><span class="dv">2</span>) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">setNames</span>(<span class="kw">paste</span>(<span class="dv">1</span><span class="op">:</span><span class="dv">2</span>, <span class="st">&quot;DLTs&quot;</span>))</a>
<a class="sourceLine" id="cb9-10" title="10"></a>
<a class="sourceLine" id="cb9-11" title="11">candidate_doses &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb9-12" title="12">  <span class="dt">group_id =</span> <span class="kw">factor</span>(<span class="st">&quot;trial_AB&quot;</span>, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb9-13" title="13">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">3</span>, <span class="fl">4.5</span>),</a>
<a class="sourceLine" id="cb9-14" title="14">  <span class="dt">drug_B =</span> <span class="dv">400</span></a>
<a class="sourceLine" id="cb9-15" title="15">)</a>
<a class="sourceLine" id="cb9-16" title="16"></a>
<a class="sourceLine" id="cb9-17" title="17">scenario_inference &lt;-<span class="st"> </span><span class="kw">lapply</span>(scenarios, <span class="cf">function</span>(scenario_newdata){</a>
<a class="sourceLine" id="cb9-18" title="18">  </a>
<a class="sourceLine" id="cb9-19" title="19">  <span class="co"># refit the model with each scenario&#39;s additional data</span></a>
<a class="sourceLine" id="cb9-20" title="20">  scenario_fit &lt;-<span class="st"> </span><span class="kw">update</span>(blrmfit, <span class="dt">add_data =</span> scenario_newdata)</a>
<a class="sourceLine" id="cb9-21" title="21">  </a>
<a class="sourceLine" id="cb9-22" title="22">  <span class="co"># summarize posterior at candidate doses</span></a>
<a class="sourceLine" id="cb9-23" title="23">  scenario_summ &lt;-<span class="st"> </span><span class="kw">summary</span>(scenario_fit,</a>
<a class="sourceLine" id="cb9-24" title="24">                           <span class="dt">newdata =</span> candidate_doses,</a>
<a class="sourceLine" id="cb9-25" title="25">                           <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="dv">1</span>))</a>
<a class="sourceLine" id="cb9-26" title="26">  </a>
<a class="sourceLine" id="cb9-27" title="27">  <span class="kw">cbind</span>(candidate_doses, scenario_summ)</a>
<a class="sourceLine" id="cb9-28" title="28">  </a>
<a class="sourceLine" id="cb9-29" title="29">})</a></code></pre></div>
<table>
<caption>Model inference when 1 DLT is observed in first cohort</caption>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.199</td>
<td align="right">0.214</td>
<td align="right">0.010</td>
<td align="right">0.128</td>
<td align="right">0.917</td>
<td align="right">0.598</td>
<td align="right">0.238</td>
<td align="right">0.165</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.262</td>
<td align="right">0.235</td>
<td align="right">0.016</td>
<td align="right">0.190</td>
<td align="right">0.950</td>
<td align="right">0.434</td>
<td align="right">0.296</td>
<td align="right">0.270</td>
</tr>
</tbody>
</table>
<table>
<caption>Model inference when 2 DLTs are observed in first cohort</caption>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.292</td>
<td align="right">0.271</td>
<td align="right">0.006</td>
<td align="right">0.199</td>
<td align="right">0.970</td>
<td align="right">0.420</td>
<td align="right">0.266</td>
<td align="right">0.314</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.365</td>
<td align="right">0.290</td>
<td align="right">0.013</td>
<td align="right">0.286</td>
<td align="right">0.987</td>
<td align="right">0.311</td>
<td align="right">0.246</td>
<td align="right">0.443</td>
</tr>
</tbody>
</table>
</div>
</div>
<div id="continuation-of-example" class="section level2">
<h2>Continuation of example</h2>
<p>In the example of [1], at the time of completion of <code>trial_AB</code>, the complete historical and concurrent data are as follows.</p>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb10-1" title="1"><span class="kw">kable</span>(codata_combo2)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">cohort_time</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">8.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">33.3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">50.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">100.0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">200.0</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">400.0</td>
<td align="right">15</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">800.0</td>
<td align="right">20</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">1120.0</td>
<td align="right">17</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">800.0</td>
<td align="right">7</td>
<td align="right">5</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">4.5</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">400.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">600.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800.0</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600.0</td>
<td align="right">10</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">400.0</td>
<td align="right">10</td>
<td align="right">3</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
<p>Numerous toxicities were observed in the concurrent <code>IIT</code> study. Through the MAC framework, these data can influence the model summaries for <code>trial_AB</code>. Note that we use the <code>update</code> function differently than before, since we specify the entire data-set now we use the <code>data</code> argument.</p>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb11-1" title="1">final_fit &lt;-<span class="st"> </span><span class="kw">update</span>(blrmfit, <span class="dt">data =</span> codata_combo2)</a>
<a class="sourceLine" id="cb11-2" title="2"></a>
<a class="sourceLine" id="cb11-3" title="3">summ &lt;-<span class="st"> </span><span class="kw">summary</span>(final_fit, newdata, <span class="dt">prob =</span> <span class="kw">c</span>(<span class="fl">0.5</span>, <span class="fl">0.95</span>), <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>,<span class="fl">0.33</span>,<span class="dv">1</span>))</a>
<a class="sourceLine" id="cb11-4" title="4"></a>
<a class="sourceLine" id="cb11-5" title="5">final_summ_stats &lt;-<span class="st"> </span><span class="kw">cbind</span>(newdata, summ) <span class="op">%&gt;%</span></a>
<a class="sourceLine" id="cb11-6" title="6"><span class="st">    </span><span class="kw">mutate</span>(<span class="dt">EWOC=</span><span class="dv">1</span><span class="op">*</span><span class="st">`</span><span class="dt">(0.33,1]</span><span class="st">`</span><span class="op">&lt;=</span><span class="fl">0.25</span>)</a></code></pre></div>
<div class="sourceCode" id="cb12"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb12-1" title="1"><span class="kw">ggplot</span>(final_summ_stats,</a>
<a class="sourceLine" id="cb12-2" title="2">       <span class="kw">aes</span>(<span class="dt">x=</span><span class="kw">factor</span>(drug_B), <span class="dt">colour=</span>EWOC)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-3" title="3"><span class="st">    </span><span class="kw">facet_wrap</span>(<span class="op">~</span>drug_A, <span class="dt">labeller=</span>label_both) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-4" title="4"><span class="st">    </span><span class="kw">scale_y_continuous</span>(<span class="dt">breaks=</span><span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="fl">0.4</span>, <span class="fl">0.6</span>, <span class="fl">0.8</span>, <span class="fl">1.0</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-5" title="5"><span class="st">    </span><span class="kw">coord_cartesian</span>(<span class="dt">ylim=</span><span class="kw">c</span>(<span class="dv">0</span>,<span class="fl">0.8</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-6" title="6"><span class="st">    </span><span class="kw">geom_hline</span>(<span class="dt">yintercept =</span> <span class="kw">c</span>(<span class="fl">0.16</span>, <span class="fl">0.33</span>),</a>
<a class="sourceLine" id="cb12-7" title="7">               <span class="dt">linetype =</span> <span class="st">&quot;dotted&quot;</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-8" title="8"><span class="st">    </span><span class="kw">geom_pointrange</span>(<span class="kw">aes</span>(<span class="dt">y=</span><span class="st">`</span><span class="dt">50%</span><span class="st">`</span>, <span class="dt">ymin=</span><span class="st">`</span><span class="dt">2.5%</span><span class="st">`</span>, <span class="dt">ymax=</span><span class="st">`</span><span class="dt">97.5%</span><span class="st">`</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-9" title="9"><span class="st">    </span><span class="kw">geom_linerange</span>(<span class="kw">aes</span>(<span class="dt">ymin=</span><span class="st">`</span><span class="dt">25%</span><span class="st">`</span>, <span class="dt">ymax=</span><span class="st">`</span><span class="dt">75%</span><span class="st">`</span>), <span class="dt">size=</span><span class="fl">1.5</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-10" title="10"><span class="st">    </span><span class="kw">ggtitle</span>(<span class="st">&quot;DLT Probability&quot;</span>, <span class="st">&quot;Shown is the median (dot), 50% CrI (thick line) and 95% CrI (thin line)&quot;</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-11" title="11"><span class="st">    </span><span class="kw">ylab</span>(<span class="ot">NULL</span>) <span class="op">+</span><span class="st"> </span></a>
<a class="sourceLine" id="cb12-12" title="12"><span class="st">    </span><span class="kw">xlab</span>(<span class="st">&quot;Dose Drug B [mg]&quot;</span>)</a></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
</div>
<div id="references" class="section level2">
<h2>References</h2>
<p>[1] Neuenschwander, B., Roychoudhury, S., &amp; Schmidli, H. (2016). On the use of co-data in clinical trials. Statistics in Biopharmaceutical Research, 8(3), 345-354.</p>
<p>[2] Neuenschwander, B., Wandel, S., Roychoudhury, S., &amp; Bailey, S. (2016). Robust exchangeability designs for early phase clinical trials with multiple strata. Pharmaceutical statistics, 15(2), 123-134.</p>
<p>[3] Neuenschwander, B., Branson, M., &amp; Gsponer, T. (2008). Critical aspects of the Bayesian approach to phase I cancer trials. Statistics in medicine, 27(13), 2420-2439.</p>
<p>[4] Neuenschwander, B., Matano, A., Tang, Z., Roychoudhury, S., Wandel, S. Bailey, Stuart. (2014). A Bayesian Industry Approach to Phase I Combination Trials in Oncology. In Statistical methods in drug combination studies (Vol. 69). CRC Press.</p>
</div>
<div id="session-info" class="section level2">
<h2>Session Info</h2>
<div class="sourceCode" id="cb13"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb13-1" title="1"><span class="kw">sessionInfo</span>()</a></code></pre></div>
<pre><code>## R version 3.6.1 (2019-07-05)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 16.04.6 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/libblas/libblas.so.3.6.0
## LAPACK: /usr/lib/lapack/liblapack.so.3.6.0
## 
## locale:
## [1] C
## 
## attached base packages:
## [1] stats     graphics  grDevices utils     datasets  methods   base     
## 
## other attached packages:
## [1] tidyr_1.0.0      dplyr_0.8.3      RBesT_1.4-0      ggplot2_3.2.1   
## [5] knitr_1.25       OncoBayes2_0.5-4 Rcpp_1.0.2      
## 
## loaded via a namespace (and not attached):
##  [1] rstan_2.19.2       tidyselect_0.2.5   xfun_0.10         
##  [4] purrr_0.3.3        colorspace_1.4-1   vctrs_0.2.0       
##  [7] htmltools_0.4.0    stats4_3.6.1       loo_2.1.0         
## [10] yaml_2.2.0         rlang_0.4.0        pkgbuild_1.0.6    
## [13] pillar_1.4.2       withr_2.1.2        glue_1.3.1        
## [16] matrixStats_0.55.0 lifecycle_0.1.0    plyr_1.8.4        
## [19] stringr_1.4.0      munsell_0.5.0      gtable_0.3.0      
## [22] mvtnorm_1.0-11     codetools_0.2-16   evaluate_0.14     
## [25] inline_0.3.15      callr_3.3.2        ps_1.3.0          
## [28] parallel_3.6.1     bayesplot_1.7.0    highr_0.8         
## [31] rstantools_2.0.0   scales_1.0.0       backports_1.1.5   
## [34] checkmate_1.9.4    StanHeaders_2.19.0 abind_1.4-5       
## [37] gridExtra_2.3      digest_0.6.21      stringi_1.4.3     
## [40] processx_3.4.1     grid_3.6.1         cli_1.1.0         
## [43] tools_3.6.1        magrittr_1.5       lazyeval_0.2.2    
## [46] tibble_2.1.3       Formula_1.2-3      crayon_1.3.4      
## [49] pkgconfig_2.0.3    zeallot_0.1.0      ellipsis_0.3.0    
## [52] prettyunits_1.0.2  ggridges_0.5.1     assertthat_0.2.1  
## [55] rmarkdown_1.16     R6_2.4.0           compiler_3.6.1</code></pre>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
